Clopenthixol
Clopenthixol (Sordinol), also known as clopentixol, is a typical antipsychotic drug of the thioxanthene class. It was introduced by Lundbeck in 1961.
- Pronethalol
- Pronethalol was an early non-selective beta blocker clinical candidate. It was never used clinically due to carcinogenicity in mice, which was thought to result from formation of a carcinogenic naphthalene epoxide metabolite
- Clebopride
- Clebopride is a dopamine antagonist drug with antiemetic and prokinetic properties used to treat functional gastrointestinal disorders. Chemically, it is a substituted benzamide, closely related to metoclopramide
- Alizapride
- Alizapride is a dopamine antagonist with prokinetic and antiemetic effects used in the treatment of nausea and vomiting, including postoperative nausea and vomiting. It is structurally related to metoclopramide and other benzamides
- Febarbamate
- Febarbamate, also known as phenobamate, is an anxiolytic and tranquilizer of the barbiturate and carbamate families which is used in Europe by itself and as part of a combination drug formulation called tetrabamate
- Glymidine sodium
- Glymidine sodium is a sulfonamide antidiabetic drug, structurally related to the sulfonylureas. It was first reported in 1964, and introduced to clinical use in Europe in the mid to late 1960s
- Almagate
- Almagate is an aluminium- and magnesium-containing antacid. It was first described in 1984
- Oxetacaine
- Oxetacaine is a potent local anesthetic. It is administered orally for the relief of pain associated with peptic ulcer disease or esophagitis. It is also used topically in the management of hemorrhoid pain. Oral oxetacaine preparations are available in
- Bephenium hydroxynaphthoate
- Bephenium hydroxynaphthoate is an anthelmintic agent formerly used in the treatment of hookworm infections and ascariasis. It is formulated as a salt between the active pharmaceutical ingredient, bephenium, and 3-hydroxy-2-naphthoic acid
- Asoxime chloride
- Asoxime chloride, or more commonly HI-6, is a Hagedorn oxime used in the treatment of organophosphate poisoning
- Cassava Sciences
- Cassava Sciences is a pharmaceutical company based in Austin, Texas, USA. Established in 1998 as Pain Therapeutics, the new name was adopted to focus on drugs for neurodegenerative diseases like Alzheimer's disease. Its founder, Chief Executive Officer